Healthcare
Nyrada Strengthens Innovation Push With Xolatryp Patent Progress
May 19, 2026 06:23 PM AEST| By SamNyrada strengthens its biotechnology portfolio after securing a key US patent milestone for Xolatryp, supporting long-term innovation in cardiac therapy research and expanding industry attention.
Island Pharmaceuticals Builds Momentum in Antiviral Space
May 19, 2026 05:26 PM AEST| By SamIsland Pharmaceuticals continues strengthening its antiviral development strategy while maintaining financial flexibility, placing the biotechnology company in focus among healthcare market watchers.
BCAL Diagnostics Broadens Early Detection Reach Across Australia
May 19, 2026 04:18 PM AEST| By SamBCAL Diagnostics is advancing early cancer detection access through national GP integration, telehealth support, and expanded healthcare infrastructure across Australia and global markets.
Pro Medicus Strengthens US Expansion With New Imaging Agreement
May 19, 2026 04:06 PM AEST| By SamPro Medicus strengthens its US healthcare footprint with a major cloud imaging agreement, highlighting growing demand for advanced medical technology solutions across global healthcare networks.
Oil Shock and Banking Drag Sink Australian Shares
May 19, 2026 03:36 PM AEST| By SamAustralian shares weakened as rising oil prices, geopolitical tensions, and heavy selling in banking and healthcare stocks triggered cautious sentiment across multiple sectors.
Market Rebound Sparks Fresh Confidence Across Australian Shares
May 19, 2026 03:28 PM AEST| By SamAustralian shares rebounded after recent market weakness as retail, healthcare, insurance, and industrial stocks regained momentum, while mining companies remained under pressure amid softer oil prices and easing geopolitical concerns.
Why These Australian Shares Are Back in the Spotlight
May 19, 2026 03:08 PM AEST| By SamAustralian healthcare, gold and consumer-focused shares are regaining momentum as market sentiment improves and investors reassess long-term growth sectors across the local equities landscape.
Why These Beaten-Down ASX Shares Are Turning Heads
May 19, 2026 02:54 PM AEST| By SamSeveral heavily sold-down Australian shares rebounded as market sentiment improved, though ongoing economic pressure, regulation, and global uncertainty continue shaping the recovery outlook across healthcare, retail, industrial, and wagering sectors...
Lithium Stock Roars Back as Woolworths Leads Market Charge
May 19, 2026 02:19 PM AEST| By SamAustralian shares advanced as supermarket stocks gained favour and lithium optimism returned after Mineral Resources restarted a major mine, while gold, healthcare and technology sectors delivered mixed market reactions.
Alcidion’s Healthcare Expansion Signals Digital Growth
May 18, 2026 05:49 PM AEST| By SamAlcidion expands its healthcare technology capabilities through a strategic acquisition, enhancing patient flow solutions, customer reach, and cloud-based healthcare innovation across Australia.
Why Pro Medicus Is Defying the Market Mood
May 18, 2026 04:23 PM AEST| By SamPro Medicus drew attention after securing a major healthcare imaging agreement in North America, reinforcing confidence around digital healthcare infrastructure and cloud-based enterprise imaging technology despite broader market weakness.
Why Pro Medicus Has the Market Watching Closely
May 18, 2026 03:45 PM AEST| By SamPro Medicus has strengthened its global healthcare technology presence through another major imaging agreement, highlighting rising demand for cloud-based medical infrastructure and enterprise diagnostic platforms.
Why This Hearing Giant’s Slump Is Turning Heads
May 18, 2026 03:29 PM AEST| By SamCochlear’s recent market decline has shifted attention toward its long-term healthcare strengths, specialised hearing technology, and growing global treatment demand despite softer market sentiment.
ASX 20 Healthcare Giant Draws Attention After Sharp Share Price Slide
May 18, 2026 10:56 AM AEST| By SamCSL remains under strong investor focus as biotechnology growth, healthcare demand, and defensive earnings themes continue shaping market sentiment.
ASX 200 Healthcare Share Faces Pressure After Guidance Reset
May 18, 2026 10:20 AM AEST| By SamHealius remains under market scrutiny as labour cost inflation, healthcare funding pressures, and operational restructuring reshape sentiment around the healthcare provider.
Could Integral Diagnostics ASX 300 Stay In Focus?
May 18, 2026 10:19 AM AEST| By SamIntegral Diagnostics remained under healthcare market attention as diagnostic imaging demand, connected healthcare systems and digital patient support platforms continued shaping Australia’s medical technology sector.
Could ResMed ASX 200 Healthcare Strength Continue?
May 17, 2026 05:33 PM AEST| By SamResMed remained under healthcare market attention as respiratory treatment systems, sleep care technologies and connected healthcare platforms continued shaping Australia’s medical technology sector.
Radiopharm Theranostics Draws Attention After Insider Buying
May 17, 2026 10:46 AM AEST| By SamRadiopharm Theranostics continues attracting market attention as insider buying activity and growing interest in precision oncology shape sentiment around the emerging healthcare company.
Why Cochlear Is Quietly Regaining Market Attention
May 17, 2026 10:43 AM AEST| By SamCochlear continues attracting investor attention as healthcare stocks regain momentum through defensive demand trends, ageing population exposure, and long-term medical technology growth themes.
Why ResMed Shares Are Back in Focus Amid Healthcare Technology Shifts
May 16, 2026 01:15 PM AEST| By SamResMed and QBE are drawing renewed attention as healthcare technology adoption, ageing populations, and financial resilience continue shaping long-term ASX market trends.
Advertise your brand on Kalkine Media